Cargando…

A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions

BACKGROUND: The spread of SARS-CoV-2, the virus that causes Coronavirus Disease 2019 (COVID-19), has been characterized as a worldwide pandemic. Currently, there are few preclinical animal models that suitably represent infection, as the main point of entry to human cells is via human angiotensin-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tseng, Ssu-Hsueh, Lam, Brandon, Kung, Yu Jui, Lin, John, Liu, Li, Tsai, Ya Chea, Ferrall, Louise, Roden, Richard B. S., Wu, T. C., Hung, Chien-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084690/ https://www.ncbi.nlm.nih.gov/pubmed/33926459 http://dx.doi.org/10.1186/s12929-021-00729-3

Ejemplares similares

Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
por: Henkle, Talia R., et al.
Publicado: (2021)

Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity
por: Tseng, Ssu-Hsueh, et al.
Publicado: (2022)

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential
por: Lam, Brandon, et al.
Publicado: (2021)

Delivery of IL-2 to the T Cell Surface Through Phosphatidylserine Permits Robust Expansion of CD8 T Cells
por: MacDonald, Alana, et al.
Publicado: (2021)

Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis
por: Tseng, Ssu-Hsueh, et al.
Publicado: (2020)

Localization of Salmonella and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity
por: Kung, Yu-Jui, et al.
Publicado: (2022)

Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice
por: Peng, Shiwen, et al.
Publicado: (2022)

Erratum for Peng et al., “Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice”
por: Peng, Shiwen, et al.
Publicado: (2022)

Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
por: Tseng, Ssu-Hsueh, et al.
Publicado: (2021)

RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
por: Soong, Ruey-Shyang, et al.
Publicado: (2016)

Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice
por: Peng, Shiwen, et al.
Publicado: (2022)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Construction and applications of SARS-CoV-2 pseudoviruses: a mini review
por: Chen, Minghai, et al.
Publicado: (2021)

A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
por: Tsai, Wen-Yang, et al.
Publicado: (2021)

Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
por: Wu, Xi, et al.
Publicado: (2023)

Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus
por: Sitjar, Jaya, et al.
Publicado: (2022)

An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
por: Yang, Peng, et al.
Publicado: (2021)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus
por: Yi, Sang Ah, et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal
por: Wang, Hai-xin, et al.
Publicado: (2022)

Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection
por: Wang, Zeng, et al.
Publicado: (2023)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022)

Hydrolysis improves the inhibition efficacy of bovine lactoferrin against infection by SARS-CoV-2 pseudovirus
por: Patil, Devashree, et al.
Publicado: (2023)

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
por: Dadonaite, Bernadeta, et al.
Publicado: (2023)

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
por: Dadonaite, Bernadeta, et al.
Publicado: (2022)

Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma
por: Yang, Pei-Ming, et al.
Publicado: (2017)

Polygoni multiflori radix extracts inhibit SARS-CoV-2 pseudovirus entry in HEK293T cells and zebrafish larvae
por: Wang, Xiaoyang, et al.
Publicado: (2022)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
por: He, Sijia, et al.
Publicado: (2020)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development
por: Huang, Sheng-Wen, et al.
Publicado: (2020)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcv46lhpvip3do6kad67kjtdl2